IRADIMED CORPORATION (IRMD) Operating margin 2016–2025
IRADIMED CORPORATION (IRMD) operating margin by fiscal year — reported operating income divided by reported revenue.
31.2%FY2025 · since FY2016: 33.6% → 31.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 31.2% | +1.2 pp |
| FY2024 | 30.0% | -0.6 pp |
| FY2023 | 30.6% | +1.2 pp |
| FY2022 | 29.3% | +5.8 pp |
| FY2021 | 23.5% | +25.9 pp |
| FY2020 | -2.4% | -24.8 pp |
| FY2019 | 22.5% | +2.7 pp |
| FY2018 | 19.7% | +14.2 pp |
| FY2017 | 5.6% | -28.0 pp |
| FY2016 | 33.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRMD financial trends
IRMD RevenueIRMD Net incomeIRMD Net marginIRMD Gross profitIRMD Gross marginIRMD Operating incomeIRMD Operating cash flowIRMD Free cash flowIRMD Capital expendituresIRMD Return on equityIRMD Stock buybacksIRMD Dividends paidIRMD Total assetsIRMD Total liabilitiesIRMD Shareholders’ equityIRMD overview →